H. Lawrence Remmel - Net Worth and Insider Trading

H. Lawrence Remmel Net Worth

The estimated net worth of H. Lawrence Remmel is at least $387 dollars as of 2024-05-11. H. Lawrence Remmel is the Director of Atossa Therapeutics Inc and owns about 260 shares of Atossa Therapeutics Inc (ATOS) stock worth over $387. Details can be seen in H. Lawrence Remmel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that H. Lawrence Remmel has not made any transactions after 2017-04-17 and currently still holds the listed stock(s).

Transaction Summary of H. Lawrence Remmel

To

H. Lawrence Remmel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, H. Lawrence Remmel owns 1 companies in total, including Atossa Therapeutics Inc (ATOS) .

Click here to see the complete history of H. Lawrence Remmel’s form 4 insider trades.

Insider Ownership Summary of H. Lawrence Remmel

Ticker Comapny Transaction Date Type of Owner
ATOS Atossa Therapeutics Inc 2017-04-17 director

H. Lawrence Remmel Latest Holdings Summary

H. Lawrence Remmel currently owns a total of 1 stock. H. Lawrence Remmel owns 260 shares of Atossa Therapeutics Inc (ATOS) as of April 17, 2017, with a value of $387.

Latest Holdings of H. Lawrence Remmel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATOS Atossa Therapeutics Inc 2017-04-17 260 1.49 387

Holding Weightings of H. Lawrence Remmel


H. Lawrence Remmel Form 4 Trading Tracker

According to the SEC Form 4 filings, H. Lawrence Remmel has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the acquisition of 208 shares on April 17, 2017, which cost H. Lawrence Remmel around $1,575.

Insider Trading History of H. Lawrence Remmel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

H. Lawrence Remmel Trading Performance

GuruFocus tracks the stock performance after each of H. Lawrence Remmel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by H. Lawrence Remmel is 4.03%. GuruFocus also compares H. Lawrence Remmel's trading performance to market benchmark return within the same time period. The performance of stocks bought by H. Lawrence Remmel within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how H. Lawrence Remmel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of H. Lawrence Remmel

Average Return

Average return per transaction

Outperforming Transactions

0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.5
Relative Return to S&P 500(%) 7.67

H. Lawrence Remmel Ownership Network

Ownership Network List of H. Lawrence Remmel

No Data

Ownership Network Relation of H. Lawrence Remmel


H. Lawrence Remmel Owned Company Details

What does Atossa Therapeutics Inc do?

Who are the key executives at Atossa Therapeutics Inc?

H. Lawrence Remmel is the director of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .

Atossa Therapeutics Inc (ATOS) Insider Trades Summary

Over the past 18 months, H. Lawrence Remmel made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .

In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.

Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Atossa Therapeutics Inc Insider Transactions

No Available Data

H. Lawrence Remmel Mailing Address

Above is the net worth, insider trading, and ownership report for H. Lawrence Remmel. You might contact H. Lawrence Remmel via mailing address: C/o Atossa Genetics, Inc., 4105 Madison Street, Suite 320, Seattle Wa 98112.

Discussions on H. Lawrence Remmel

No discussions yet.